MCRT Stock Overview
Microart Inc. researches and develops innovative stem cell solutions and therapeutic applications of adult stem cells.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Microart Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.0002 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| MCRT | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | -4.7% | -3.7% |
| 1Y | n/a | -2.7% | 20.2% |
Return vs Industry: Insufficient data to determine how MCRT performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how MCRT performed against the US Market.
Price Volatility
| MCRT volatility | |
|---|---|
| MCRT Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MCRT has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MCRT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | n/a | Tsap Ping | n/a |
Microart Inc. researches and develops innovative stem cell solutions and therapeutic applications of adult stem cells. The company develops and commercializes cell-based anti-aging research and cosmetic products. Microart Inc. also develops proprietary technology for the treatment of diabetes.
Microart Inc. Fundamentals Summary
| MCRT fundamental statistics | |
|---|---|
| Market cap | US$26.15k |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MCRT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCRT income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MCRT perform over the long term?
See historical performance and comparison